seliciclib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for seliciclib, covering 2012-06-26 to 2012-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC) [Phase 1]